Otilimab (Anti-CSF2 / GM-CSF)

Synonyms: GSK 3196165; MOR103

Otilimab (GSK 3196165) is an humanized monoclonal antibody targeting GM-CSF (granulocyte-macrophage colony-stimulating factor). Otilimab neutralises the biological function of GM-CSF by blocking the interaction of GM-CSF with its cell surface receptor. MW: 145.5 KD.

Otilimab (Anti-CSF2 / GM-CSF)

Purity & Quality Control

Batch: A253301 Purity: 99% Protein concentration: 9.35mg/ml Endotoxin Level: <1EU/mg
99

Biological Activity

Description Otilimab (GSK 3196165) is an humanized monoclonal antibody targeting GM-CSF (granulocyte-macrophage colony-stimulating factor). Otilimab neutralises the biological function of GM-CSF by blocking the interaction of GM-CSF with its cell surface receptor. MW: 145.5 KD.

Product Details

CAS No. 1638332-55-4
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Otilimab (Anti-CSF2 / GM-CSF) | Otilimab (Anti-CSF2 / GM-CSF) supplier | purchase Otilimab (Anti-CSF2 / GM-CSF) | Otilimab (Anti-CSF2 / GM-CSF) cost | Otilimab (Anti-CSF2 / GM-CSF) manufacturer | order Otilimab (Anti-CSF2 / GM-CSF) | Otilimab (Anti-CSF2 / GM-CSF) distributor